The $70 central target is the arithmetic mean of 12 recent, individually attributed analyst price targets, rounded from a calculated mean of $69.25. At a recent price near $34.73, reaching $70 would require roughly 101% upside, a very large move.

Citigroup reported net income of $5.2 billion , with diluted earnings per share (EPS) of $2.85 , beating the analyst consensus of $2.65. Revenue rose 8% year over year to $23.85 billion , the bank's strongest third-quarter revenue in a decade, topping estimates of roughly $23.72 billion.

Wells Fargo reported third quarter 2026 net income of $5.95 billion, up 6% from $5.58 billion a year earlier. Diluted earnings per share (EPS) rose 13% to $1.87, slightly ahead of the consensus estimate of approximately $1.85–$1.86.

Goldman Sachs reported net revenues of $18.68 billion, up 23% year over year and its second-highest quarterly total on record. Diluted earnings per share (EPS) of $17.01 surged 39% from $12.25 a year earlier and beat consensus estimates by a wide margin.

UnitedHealth reported third quarter 2026 revenue of $112.7 billion and adjusted earnings per share (EPS) of $4.69 , beating the analyst consensus of roughly $4.14. The medical care ratio (MCR), the share of premium revenue paid out for medical claims, improved to 88.4% from 89.9% a year earlier and came in below expectations.

Johnson & Johnson reported third-quarter 2026 revenue of $25.4 billion , up 5.9% year over year and slightly ahead of the roughly $25.38 billion consensus. Adjusted EPS (earnings per share) came in at $2.59 , beating the $2.53 estimate, though down 7.5% from $2.80 a year earlier on acquisition-related costs.

JPMorgan Chase reported third-quarter 2026 net income of $15.3 billion, up 6% year over year, with diluted earnings per share (EPS) of $5.57. Managed revenue reached $50.9 billion, up 8% year over year, but came in slightly below Wall Street consensus estimates.

The $4.50 objective is a technical milestone — the stock's 52-week high — not an analyst price target; Alaunos Therapeutics, Inc. (TCRT) has essentially no usable analyst coverage today. The stock closed at $3.03 on October 13, 2026, up roughly 189% in a single session after announcing a reverse merger with Velaris Therapeutics and a $350 million private placement.

PMAX fell -9.38% during regular trading, last quoted near $0.58 versus a $0.64 prior-session close. The thinly traded micro-cap (market cap ~$1.5M) extended its decline as selling pressure persists in a highly volatile name.

Net revenues reached $18.68 billion, up 23% year over year, the second-highest quarterly total in the firm's history. Diluted earnings per share (EPS) came in at $17.01, well above the roughly $13.09 consensus estimate and up 39% from $12.25 a year earlier.

UnitedHealth reported third quarter 2026 revenue of $112.7 billion, slightly lower than a year ago but ahead of the $111.31 billion consensus estimate. Adjusted earnings per share (EPS) came in at $4.69, beating the roughly $4.14 Wall Street estimate and rising sharply from $2.92 a year earlier.

Goldman Sachs reported third-quarter 2026 diluted earnings per share (EPS) of $17.01, up 39% from $12.25 a year earlier and well above analyst expectations. Net revenues reached $18.68 billion, a 23% year-over-year increase and the second-highest quarterly total in the firm's history.

Diluted earnings per share (EPS) rose 13% year over year to $1.87, slightly above the $1.85 consensus estimate. Revenue reached $21.87 billion, up 2% from a year earlier but below the roughly $22.31 billion analysts expected.

Citigroup reported third-quarter 2026 net income of $5.25 billion, up 40% from $3.75 billion a year earlier. Diluted earnings per share (EPS) reached $2.85, above the FactSet consensus estimate of $2.65.

Domino's Pizza (DPZ) reported third-quarter 2026 diluted earnings per share (EPS) of $4.60 , up 12.7% year over year and above Wall Street consensus estimates. Total revenue rose 3.4% to $1.19 billion , narrowly topping expectations, driven by supply chain growth and franchise royalties.

The central target of $6.90 is the arithmetic mean of the three analyst price targets currently tracked for NextTrip, Inc. (NTRP) , which range from $5.00 to $8.00. At a recent price of roughly $1.83, reaching $6.90 would require an upside of about 277%—a very large move for any stock, especially a micro-cap.

Unity Bancorp reported net income of $17.4 million , or $1.70 per diluted share , for the quarter ended September 30, 2026, up from $14.5 million, or $1.42 per diluted share, in the prior quarter. The quarter included a one-time $2.5 million benefit from the purchase of transferable federal investment tax credits, which lowered the effective tax rate to 13.1%.

AZZ reported record second-quarter sales of $486.9 million , up 16.7% year over year, topping the consensus estimate of roughly $463.2 million. Adjusted diluted earnings per share (EPS) reached $2.00 , beating the consensus estimate of $1.85 and rising 29% from the prior-year period.

Adjusted earnings per share (EPS) of $0.36 beat the consensus estimate of $0.33 by $0.03. Revenue of $18.89 billion matched analyst forecasts but slipped 0.1% year over year.

Rio Tinto reported net earnings of US$6.66 billion for the six months ended 30 June 2026, up 47% from US$4.53 billion a year earlier. Consolidated sales revenue rose 15% to US$31.03 billion , while underlying EBITDA (earnings before interest, taxes, depreciation, and amortization) climbed 28% to US$14.83 billion.